Skip to search formSkip to main contentSkip to account menu

Vaccines

Known as: VaccineEntityType, [IM100] VACCINES, vaccine product 
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio… 
National Institutes of Health

Related topics

Related topics

43 relations

Narrower (22)

0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled SyringeAdenovirus Type 4 Vaccine Live 32000 UNT Delayed Release Oral TabletBM86 protein, Boophilus

Broader (3)

Biological FactorsBiological ProductsImmunologic Factors
In BloodLot number:ID:Pt:Vaccine:NomManufacturer name:ID:Pt:Vaccine:NomPolysaccharide Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Pharmacologic treatment of SARS: current knowledge and recommendations.
The severe acute respiratory syndrome (SARS) pandemic caught the world by surprise in 2003 and spread rapidly within a relatively… 
Highly Cited
2005
Highly Cited
2005
The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response.
Review
2002
Review
2002
DNA vaccination in the avian.
Highly Cited
2001
Highly Cited
2001
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.
Highly Cited
1999
Highly Cited
1999
Immunogenicity of DNA Vaccines Expressing Tuberculosis Proteins Fused to Tissue Plasminogen Activator Signal Sequences
ABSTRACT Novel tuberculosis DNA vaccines encoding native ESAT-6, MPT-64, KatG, or HBHA mycobacterial proteins or the same… 
Review
1999
Review
1999
Immunization of animals: from DNA to the dinner plate.
Highly Cited
1998
Highly Cited
1998
Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
Mucosal tissues are major sites of HIV entry and initial infection. Thus, the induction of a mucosal cytotoxic T lymphocyte (CTL… 
Highly Cited
1991
Highly Cited
1991
Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines
Previous studies with saccharide-protein conjugates have demonstrated that antibody responses to the saccharide can be improved… 
Highly Cited
1988
Highly Cited
1988
Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
Review
1983
Review
1983
Synthetic peptide immunogens as vaccines.
Synthetic peptide immunogens have been shown to elicit antibodies that can react with full-length proteins containing that… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)